HomeRAPP • NASDAQ
add
Rapport Therapeutics Inc
Previous close
$28.05
Day range
$25.89 - $29.22
Year range
$16.55 - $29.74
Market cap
949.16M USD
Avg Volume
213.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 20.80M | 213.73% |
Net income | -18.12M | -182.65% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -20.59M | -211.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 336.14M | — |
Total assets | 346.10M | — |
Total liabilities | 9.21M | — |
Total equity | 336.89M | — |
Shares outstanding | 36.58M | — |
Price to book | 3.05 | — |
Return on assets | -18.83% | — |
Return on capital | -19.41% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -18.12M | -182.65% |
Cash from operations | -16.35M | -147.80% |
Cash from investing | -107.10M | -124,439.53% |
Cash from financing | 159.35M | 177,158.89% |
Net change in cash | 35.90M | 629.85% |
Free cash flow | -12.26M | — |
About
Founded
2022
Headquarters
Website
Employees
58